Seeking Alpha

  Threshold Pharmaceuticals, Inc. - NASDAQ

10/30/2014, 6:55 PM ET
  • The Scientist | Send Message 7 Aug 2012

    THLD Th-302 OS panc CA data likely to b > Abraxane OS. Abrax trial began 3/09. Near end of trial on 9/11, protocol changed and added 210 pts
    Reply (3)
  • View all 3 replies
    • The Scientist | Send Message 7 Aug 2012
      : Th-302 targets hypoxic niche, which should also kill CSCs.
    • Noreika | Send Message 8 Aug 2012
      : OT- That was a bummer yesterday that Bapi got cancelled. I really thought the Apo4 non-carriers would have some positive news.
      THLD vs. ETF Alternatives
      Company Description
      Threshold Pharmaceuticals, Inc. is a biotechnology company. It focuses on the discovery and development of drugs targeting the microenvironment of solid tumors as novel treatments for patients living with cancer.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States